Transforming Production Processes in the Pharmaceutical Industry
In the dynamic landscape of pharmaceutical manufacturing, the AspenTech Pharma Suite offers a comprehensive solution to digitally transform production processes. By leveraging Manufacturing Execution Systems (MES), this suite empowers pharmaceutical companies to reduce risks, enhance efficiency, and ensure compliance with regulatory standards. Manual documentation processes are no longer feasible in the face of increasing market demands, regulatory requirements, and sustainability goals. Therefore, a digital transformation through a pharma MES is crucial. This transformation is essential to increase production quality, reduce waste, time, and costs, as well as respond rapidly and mitigate risks.
Key Features and Benefits of AspenTech Pharma Suite
The AspenTech Pharma Suite focuses on safeguarding data integrity and transparency by automating, guiding, and digitally recording procedures in alignment with cGMP guidelines. By generating electronic batch records and embedded audit trails compliant with FDA 21 CFR Part 11 and EU Annex 11, this suite ensures regulatory compliance. Moreover, it enables pharmaceutical companies to achieve greater product traceability through integrated batch genealogy and visualization.
Seamless Integration and Reliability in Pharmaceutical Manufacturing
With a foundation that seamlessly integrates with all supporting enterprise-wide production functions, the AspenTech Pharma Suite brings reliability and consistency to pharmaceutical manufacturing. By streamlining processes, increasing visibility, and enhancing operational efficiency, this suite supports pharmaceutical companies in meeting the challenges of a rapidly evolving industry landscape. Through a digital transformation journey towards Pharma 4.0, companies can accelerate their progress and stay ahead of the curve.
Customer Testimonial and Endorsement
"We view our Electronic Batch Record System (eBRS) as an incredible transformation program we are deploying to make our Digital Data & Analytics (DDA) strategy a reality. DDA will enable us to deliver our Pharma Supply Chain Future-Ready Ambition." - Andrew Jenkins, Manufacturing Platform Director, GSK. This testimonial exemplifies the transformative impact of AspenTech Pharma Suite in empowering pharmaceutical companies to elevate their manufacturing capabilities.